310. Congenital anomalies syndrome Clinical trials / Disease details


Clinical trials : 10 Drugs : 18 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 7

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04381897
(ClinicalTrials.gov)
May 1, 20226/5/2020Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange SyndromeUse of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot StudyCornelia de Lange SyndromeDrug: N-acetyl cysteine;Other: PlaceboJohns Hopkins UniversityCornelia de Lange Syndrome FoundationNot yet recruiting13 Years35 YearsAll10Phase 2United States